ROTHBLATT MARTINE A (Chairperson & CEO) sold 2.8% of their position (9.50K shares) of UNITED THERAPEUTICS CORP on the open market
Open‑market sale worth $4.89M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+9.50K
Price / share
$135.42
Trade value
$1.29M
% of position
Common Stock
Shares
−40.00
Price / share
$507.08
Trade value
$20.28K
% of position
Common Stock
Shares
−440.00
Price / share
$508.86
Trade value
$223.90K
% of position
Common Stock
Shares
−280.00
Price / share
$509.61
Trade value
$142.69K
% of position
Common Stock
Shares
−1.15K
Price / share
$511.12
Trade value
$588.81K
% of position
Common Stock
Shares
−542.00
Price / share
$511.75
Trade value
$277.37K
% of position
Common Stock
Shares
−1.21K
Price / share
$513.02
Trade value
$618.70K
% of position
Common Stock
Shares
−558.00
Price / share
$514.18
Trade value
$286.91K
% of position
Common Stock
Shares
−893.00
Price / share
$514.87
Trade value
$459.78K
% of position
Common Stock
Shares
−940.00
Price / share
$516.16
Trade value
$485.19K
% of position
Common Stock
Shares
−1.25K
Price / share
$517.21
Trade value
$646K
% of position
Common Stock
Shares
−320.00
Price / share
$518.16
Trade value
$165.81K
% of position
Common Stock
Shares
−1.16K
Price / share
$519.49
Trade value
$602.61K
% of position
Common Stock
Shares
−679.00
Price / share
$520.38
Trade value
$353.34K
% of position
Common Stock
Shares
−41.00
Price / share
$520.96
Trade value
$21.36K
% of position
Net shares
+0.00
Net value
-$3.61M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/12/2026 | M · Option Exercise | +9.50K | $135.42 | $1.29M | 2.9% | 324.44K | 333.94K |
| Common Stock Indirect | 8/12/2026 | S · Sale | −40.00 | $507.08 | $20.28K | 0.0% | 333.94K | 333.90K |
| Common Stock Indirect | 8/12/2026 | S · Sale | −440.00 | $508.86 | $223.90K | 0.1% | 333.90K | 333.46K |
| Common Stock Indirect | 8/12/2026 | S · Sale | −280.00 | $509.61 | $142.69K | 0.1% | 333.46K | 333.18K |
| Common Stock Indirect | 8/12/2026 | S · Sale | −1.15K | $511.12 | $588.81K | 0.3% | 333.18K | 332.03K |
| Common Stock Indirect | 8/12/2026 | S · Sale | −542.00 | $511.75 | $277.37K | 0.2% | 332.03K | 331.49K |
| Common Stock Indirect | 8/12/2026 | S · Sale | −1.21K | $513.02 | $618.70K | 0.4% | 331.49K | 330.28K |
| Common Stock Indirect | 8/12/2026 | S · Sale | −558.00 | $514.18 | $286.91K | 0.2% | 330.28K | 329.73K |
| Common Stock Indirect | 8/12/2026 | S · Sale | −893.00 | $514.87 | $459.78K | 0.3% | 329.73K | 328.83K |
| Common Stock Indirect | 8/12/2026 | S · Sale | −940.00 | $516.16 | $485.19K | 0.3% | 328.83K | 327.89K |
| Common Stock Indirect | 8/12/2026 | S · Sale | −1.25K | $517.21 | $646K | 0.4% | 327.89K | 326.64K |
| Common Stock Indirect | 8/12/2026 | S · Sale | −320.00 | $518.16 | $165.81K | 0.1% | 326.64K | 326.32K |
| Common Stock Indirect | 8/12/2026 | S · Sale | −1.16K | $519.49 | $602.61K | 0.4% | 326.32K | 325.16K |
| Common Stock Indirect | 8/12/2026 | S · Sale | −679.00 | $520.38 | $353.34K | 0.2% | 325.16K | 324.48K |
| Common Stock Indirect | 8/12/2026 | S · Sale | −41.00 | $520.96 | $21.36K | 0.0% | 324.48K | 324.44K |
| Total | +0.00 | -$3.61M | ||||||
Stock Option
Common Stock
9.50K shares
Shares
−9.50K
Strike price
135.42
Held after
151.41K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Indirect | Common Stock9.50K shares | 8/12/2026 | M · Option Exercise | −9.50K | 135.42 | — | 151.41K |
Common Stock
DirectCommon Stock
IndirectCommon Stock
IndirectCommon Stock
IndirectCommon Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 40.51K | Direct |
| Common Stock | 166.00 | Indirect |
| Common Stock | 8.90K | Indirect |
| Common Stock | 249.11K | Indirect |
| Common Stock | 45.60K | Indirect |
| Total | 344.29K | 40.51K direct·303.77K indirect |